ClinicalTrials.gg
RecruitingNCT07166055DanceDiversityUpdated Oct 15, 2026

Feasibility Trial of Family-Centered Therapeutic Dance for Children With Disabilities

An interventional study of Therapeutic dance in Children With Disabilities, sponsored by University of Valencia. Recruiting at 1 site in Spain. Open to participants aged 3 Years to 14 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by University of Valencia · Not applicable, Interventional, and Treatment

How we know

Updated Oct 15, 2026Start date movedEnrollment updated+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
3 Years to 14 Years
Sex
All
01

Study summary

The primary aim of this exploratory cluster-randomized trial is to assess the feasibility and acceptability of delivering a school-based group therapeutic dance program through a family-centered approach for children with disabilities and to generate preliminary estimates of intervention effects and outcome variability to inform the design of a future definitive cluster-randomized controlled trial.

No confirmatory effectiveness hypothesis is prespecified for this exploratory trial. Instead, the study will estimate the direction, magnitude, and precision of pre-liminary between-group differences in the primary and secondary clinical outcomes and will characterize feasibility and implementation parameters relevant to a future definitive trial.

Read the detailed description

This protocol describes the DanceDiversity trial, an exploratory cluster-randomized feasibility trial designed to evaluate the feasibility and acceptability of a school-based, group therapeutic dance intervention delivered through a family-centered approach for children with disabilities, while generating preliminary estimates of its potential clin-ical effects on individualized occupational performance. Methods: A two-arm, paral-lel-group, assessor-blinded, cluster-randomized feasibility trial will be conducted across 6-10 participating schools. All 10 eligible schools will be invited to participate, with 6 schools representing the anticipated minimum recruitment scenario. Participating schools will be allocated in a 1:1 ratio, using restricted randomization stratified by school type, to either the DanceDiversity experimental group (EG) or a waitlist control group (CG). Approximately 36-60 children with disabilities will be enrolled, depending on the number of participating schools. Baseline assessments will occur prior to alloca-tion disclosure. The EG will receive a 29-week therapeutic dance program consisting of two 60-minute group sessions per week, whereas the CG will maintain usual activities and will be offered the intervention following post-intervention assessment. Outcomes will be evaluated by two blinded independent physical therapists. The primary clinical outcome will be individualized occupational performance, measured by the Canadian Occupational Performance Measure (COPM) performance score. Secondary outcomes assessed in both arms will include the COPM satisfaction score, participation, health-related quality of life, gross motor function, functional mobility, functional bal-ance, walking speed, and passive lower-limb range of motion. Goal Attainment Scaling will be evaluated exclusively within the EG as an exploratory individualized outcome. Prospective feasibility criteria covering recruitment, retention, attendance, and inter-vention fidelity, together with perceived session enjoyment, will also be monitored within the EG.

02

Conditions studied

  • Children With Disabilities

Keywords

  • dance therapy
  • motor impairment
  • dance movement therapy
  • neurological disease
03

In context

Nervous System Diseases

759 studies on the registry are indexed under Nervous System Diseases; 217 are open to participants now.

This study's planned enrollment of 36 is below the median of 55 across 496 interventional studies indexed under Nervous System Diseases.

Browse Nervous System Diseases studies →

Lead sponsor

University of Valencia is the lead sponsor of 357 studies on the registry; 75 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • children with motor impairment
  • aged between 3-14 years
  • who can cognitively follow simple tasks

Exclusion criteria

Exclusion Criteria:

  • having suffered a serious clinical condition or surgical intervention in the last 6 months.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Experimental group

    Participants in this group will receive DanceDiversity, a manualized, physical therapist-led therapeutic dance intervention delivered over 29 weeks during the academic year (two 60-minute group sessions per week).

    Other: Therapeutic dance

  • No intervention
    Control group

    Participants in the waitlist control group will continue their usual school-based activities throughout the study period and will be invited to receive the therapeutic dance intervention during the subsequent academic cycle.

Interventions

  • OtherTherapeutic dance

    The protocol includes two sessions per week of therapeutic dance, during the academic year.

06

What researchers measure

Primary outcomes

  1. The Canadian Occupational Performance Measure (COPM).

    The COPM performance score will be used to assess children's and families' perceptions of performance and satisfaction regarding individualized activity and participation goals. The COPM is a standardized, client-centered, semi-structured interview widely validated in pediatric rehabilitation and designed to identify priorities in meaningful everyday activities. For each identified goal, performance and satisfaction will be rated on a 10-point scale (1 = poor/unsatisfied to 10 = excellent/extremely satisfied). The COPM will be administered as a joint child-caregiver interview rather than through separate self- and proxy-reports.

    Time frame: Baseline (pre-intervention) and immediately post-intervention.

Secondary outcomes

  1. Quality of life with the Pediatric Quality of Life Inventory (PEDS QL)

    A tool used to measure the health-related quality of life in children and adolescents, both with and without health conditions.

    Time frame: Baseline (pre-intervention) and immediately post-intervention.

  2. Gross Motor Function Measure (GMFM-88).

    Is an assessment tool designed and evaluated to measure changes in gross motor function over time or with intervention in children with cerebral palsy.

    Time frame: Baseline (pre-intervention) and immediately post-intervention.

  3. Pediatric Balance Scale

    The scale consists of 14 balance-related test items that are scored from 0 points (lowest function) to 4 points (highest function) with a maximum score of 56.

    Time frame: Baseline (pre-intervention) and immediately post-intervention.

  4. Timed up and go test (TUG)

    This test involves a series of actions that assess an individual's mobility and balance. It requires the individual to rise from a seated position in a standard chair, walk a distance of three meters, turn around, walk back to the chair, and sit down again. The time it takes to complete this sequence is recorded.

    Time frame: Baseline (pre-intervention) and immediately post-intervention.

  5. Joint ranges

    The joint ranges of the hip, knee and ankle in the three planes of movement will be carried out with a goniometer.

    Time frame: Baseline (pre-intervention) and immediately post-intervention.

Other outcomes

  1. Goal Attainment Scale (GAS).

    Goal Attainment Scaling (GAS) is a method of scoring the extent to which patient's individual goals are achieved in the course of intervention.

    Time frame: Baseline (pre-intervention) and immediately post-intervention.

07

Study locations

1 of 1 sites recruiting
  • University of Valencia
    Valencia, 46010, Spain
    Recruiting
    • M.Luz Sánchez-Sánchez, Professor · ContactM.Luz.Sanchez@uv.es · 0034-963 98 38 55
    • Mireia Fuster Espí, MSD · Principal investigator
    • Marina Vidal Pedrós, MSD · Sub investigator
    • Clara Pujol Fuentes, MSD · Sub investigator
08

References and documents

Individual participant data

Plan to share: Yes — Anonymized data may be shared with other researchers upon a reasonable request made to the project's principal investigator. Study Protocol will be published.

Supporting information: Study protocol, Informed consent form

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Jul 2027, 9 months later.

Of 168 non-industry interventional studies with no phase under Nervous System Diseases, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 57. This study's planned 9 months is below that.

Counting every sponsor, half of 194 studies reached it within 30 months; a quarter within 11 and three quarters within 54.

Nervous System Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

Start moved once since we started tracking on Sep 25, 2026: Sep 2025 → Oct 2026, on Oct 15, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 2, 2025
First posted
Sep 10, 2025
StartEst.
Oct 26, 2026was Sep 2025
Primary completionEst.
Jul 2027
CompletionEst.
Jul 2027
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Sep 15, 2025→Oct 26, 2026
Oct 15, 2026
Enrollment
30→36
Oct 15, 2026
Interventions
Arm changed Dance group→Experimental group
Oct 15, 2026
Primary outcomes
1 removed, 1 description edited
What changed in the outcomes
  • RemovedGoal Attainment Scale (GAS).Time frame: Baseline (pre-intervention) and immediately post-intervention.
  • DescriptionThe Canadian Occupational Performance Measure (COPM).: how it is measured was reworded
Oct 15, 2026
Secondary outcomes
1 added
What changed in the outcomes
  • Addedother outcomeGoal Attainment Scale (GAS).Time frame: Baseline (pre-intervention) and immediately post-intervention.
Oct 15, 2026
Title
Effect of Dance on the Parameters of the ICF in Children With Functional Diversity→Feasibility Trial of Family-Centered Therapeutic Dance for Children With Disabilities
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    Start date Sep 15, 2025→Oct 26, 2026
    Enrollment 30→36
    Primary outcomes 1 removed, 1 description edited
    What changed in the outcomes
    • RemovedGoal Attainment Scale (GAS).Time frame: Baseline (pre-intervention) and immediately post-intervention.
    • DescriptionThe Canadian Occupational Performance Measure (COPM).: how it is measured was reworded
    Secondary outcomes 1 added
    What changed in the outcomes
    • Addedother outcomeGoal Attainment Scale (GAS).Time frame: Baseline (pre-intervention) and immediately post-intervention.
    Interventions Arm changed Dance group→Experimental group
    Title Effect of Dance on the Parameters of the ICF in Children With Functional Diversity→Feasibility Trial of Family-Centered Therapeutic Dance for Children With Disabilities
    + 3 other changes: verification date, description and criteria formatting

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07166055
Responsible party
M Luz Sanchez (Professor, University of Valencia) — Principal investigator
First posted
Sep 10, 2025
Start date
Oct 26, 2026 (estimated)
Primary completion
Jul 2027 (estimated)
Completion
Jul 2027 (estimated)
Last update
Oct 15, 2026

Study contacts

M.Luz Sánchez-Sánchez
Contact
m.luz.sanchez@uv.es
0034 963983853

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion